THE VALUE OF THE IMMUNOHISTOCHEMISTRY FOR TARGET THERAPY AND PROGNOSIS IN ONCOLOGY
Target therapy is one of the most prospective pathways of oncologic diseases treatment. Many successful results have been by now obtained using targeted drugs in treatment of breast cancer, GIST's, neuroendocrine neoplasms, lung cancer, and other neoplasms. All this became possible due to immunohistochemical detection of specific molecular targets. In the nearest future, new lines of target therapy drugs are expected to appear which will require the immunohistochemical evaluation of target molecules in tumor cells.